| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:54 | Prepayments, Realkredit Danmark A/S | ||
| 13:54 | RedCloud Holdings plc: RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue | ||
| 13:54 | Artelo Biosciences: Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile | ||
| 13:48 | Psyence Biomedical Ltd.: Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source | ||
| 13:36 | Nexera Technologies Ltd: Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System | ||
| 13:36 | Xtract One Technologies Inc.: Xtract One Selected by Health PEI for Phased Rollout of Tech-Driven Security Systems Across Prince Edward Island | ||
| 13:36 | Palvella Therapeutics Inc.: Palvella Therapeutics to Present QTORIN Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026 | ||
| 13:36 | Winshear Metals Corp.: Winshear Grants 2,000,000 Stock Options | ||
| 13:30 | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | ||
| 13:30 | ISS A/S: Transactions in connection with share buyback programme | ||
| 13:06 | Gilat Satellite Networks Ltd.: Gilat to Report First Quarter 2026 Results on Wednesday, May 13th | ||
| 13:06 | Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit | ||
| 13:06 | Seres Therapeutics, Inc.: Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 | ||
| 13:06 | SPARC AI INC: SPARC AI Signs Second Ukrainian Drone Manufacturer, Expanding Distribution Footprint for GPS-Denied Software Platform | ||
| 13:06 | Emerita Resources Corp.: Emerita Announces Board and Management Transitions | ||
| 13:06 | NetraMark Holdings Inc.: Netramark Comments on U.S. Executive Order to Accelerate Treatments for Serious Mental Illness and Highlights the Need for Regulatory-Grade Trial Design in Psychedelic Development | ||
| 13:06 | NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality | ||
| 13:06 | Monte Rosa Therapeutics, Inc.: Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified ... | ||
| 13:06 | Brady Corporation to Acquire Honeywell's Productivity Solutions and Services Business, Expanding Portfolio with Data Capture and Workflow Solutions | ||
| 12:54 | Royal UNIBREW A/S: Share buy-back Program | ||
| 12:36 | Parsons Corporation: Parsons Demand Response Technology to Optimize and Enable Los Angeles Department of Water & Power's Operations and Strategic Plan | ||
| 12:36 | Kanzhun Limited: BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB913 Million in 2026 | ||
| 12:36 | Prelude Therapeutics, Incorporated: Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering | ||
| 12:06 | HEINEKEN Holding NV: Heineken Holding N.V. reports transactions under its current share buyback programme | ||
| 12:06 | Perspective Therapeutics, Inc.: Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-a-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting |